These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8464755)

  • 1. [Immunogenic hyperthyroidism following radioiodine ablation of a focal autonomy].
    Boddenberg B; Voth E; Schicha H
    Nuklearmedizin; 1993 Feb; 32(1):18-22. PubMed ID: 8464755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Incidence of immunogenic hyperthyroidism after radioiodine therapy of focal thyroid gland autonomy. Results of a multicenter study].
    Weiss M; Görges R; Hirsch C; Bader J; Tatsch K; Hahn K
    Med Klin (Munich); 1999 May; 94(5):239-44. PubMed ID: 10408185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of postradioiodine immunogenic hyperthyroidism/Graves' disease in relation to a temporary increase in thyrotropin receptor antibodies after radioiodine therapy for autonomous thyroid disease.
    Schmidt M; Gorbauch E; Dietlein M; Faust M; Stützer H; Eschner W; Theissen P; Schicha H
    Thyroid; 2006 Mar; 16(3):281-8. PubMed ID: 16571091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA damage and its repair in lymphocytes and thyroid nodule cells during radioiodine therapy in patients with hyperthyroidism.
    Grzesiuk W; Nieminuszczy J; Kruszewski M; Iwanienko T; Plazinska M; Bogdanska M; Bar-Andziak E; Królicki L; Grzesiuk E
    J Mol Endocrinol; 2006 Dec; 37(3):527-32. PubMed ID: 17170092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years' retrospective study.
    Ceccarelli C; Bencivelli W; Vitti P; Grasso L; Pinchera A
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):331-5. PubMed ID: 15730415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioiodine therapy of thyroid autonomy.
    Reiners C; Schneider P
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S471-8. PubMed ID: 12192548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioiodine therapy of the autonomous thyroid nodule in patients with or without visible extranodular activity.
    Als C; Rösler H; Kinser JA
    J Nucl Med; 1996 Feb; 37(2):401-3. PubMed ID: 8667087
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in thyroid volume after radioactive iodine therapy in patients with single toxic thyroid nodule].
    Gołkowski F; Jabrocka-Hybel A; Huszno B
    Przegl Lek; 2005; 62(5):284-6. PubMed ID: 16334533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of iodine application during radioiodine therapy in patients with impending therapy failure].
    Urbannek V; Schmidt M; Moka D; Hillger HW; Voth E; Wellner U; Schicha H
    Nuklearmedizin; 2000; 39(4):108-12. PubMed ID: 10919161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Paradoxical effect of radioiodine therapy in functional thyroid autonomy and mild immunothyropathy].
    Dunkelmann S; Rudolph F; Prillwitz A; Groth P; Schümichen C
    Nuklearmedizin; 1998 Jan; 37(1):23-9. PubMed ID: 9467166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graves' ophthalmopathy and 131I therapy.
    Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Mazzi B; Rocchi R; Barbesino G; Pinchera A
    Q J Nucl Med; 1999 Dec; 43(4):307-12. PubMed ID: 10731781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Choice of therapy in unifocal functional autonomy of the thyroid gland with hyperthyroidism].
    Als C; Baer HU; Glaser C; Rösler H
    Schweiz Med Wochenschr; 1997 May; 127(21):891-8. PubMed ID: 9289816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioiodine therapy of the autonomous thyroid nodule in patients with or without visible extranodular activity.
    Clerc J; Dagousset F; Izembart M; Jais JP; Heshmati HM; Alcaïs A; Chevalier A; Léger AF; Barritault L
    J Nucl Med; 1995 Feb; 36(2):217-23. PubMed ID: 7830117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radiometabolic therapy of the autonomous thyroid nodule].
    Mariotti S; Caturegli P; Barbesino G; Ceccarelli C; Lippi F; Marinò M; Manetti L; Martino E; Pinchera A
    Minerva Endocrinol; 1993 Dec; 18(4):155-63. PubMed ID: 8190055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use and efficacy of radioiodine therapy in the treatment of hyperthyroidism].
    Mihailović J; Malesević M; Stefanović L; Krkljus D
    Med Pregl; 1995; 48(11-12):412-5. PubMed ID: 8643057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience with ambulatory radioiodine therapy of hyperthyroidism].
    Róka R; Séra T; Valkusz Z; Julesz J; Csernay L; Pávics L
    Orv Hetil; 1999 Jun; 140(23):1291-5. PubMed ID: 10412264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of standard ten millicurie dose of radio-iodine in management of autonomously functioning toxic thyroid nodules.
    Sharma R; Bhatnagar A; Mondal A; Kashyap R; Khanna CM
    J Assoc Physicians India; 1995 Mar; 43(3):167-9, 172. PubMed ID: 11256900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Body weight gain after radioiodine therapy in hyperthyroidism].
    Scheidhauer K; Odatzidu L; Kiencke P; Schicha H
    Nuklearmedizin; 2002 Feb; 41(1):47-51. PubMed ID: 11917349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.